Answers are grounded in this paper and cite their sources.
Observational analysis shows RIOK1 inhibits glioma cell growth in IDH wild-type gliomas, suggesting a potential therapeutic target.
RIOK1 expression is lower in glioma tissues than in non-tumor brain tissues, and is particularly lower in IDH wild-type gliomas. RIOK1 functions as a suppressor of glioma cell survival and proliferation, possibly through mTOR pathway inhibition and apoptotic pathway activation.
No takes yet. Share an insight, caveat, or question.
Ji et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: